Cargando…

Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience

Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine is: the delivery of health care services, where distance is a critical factor, by all health care professionals using...

Descripción completa

Detalles Bibliográficos
Autor principal: de Kreutzenberg, Saula Vigili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111950/
https://www.ncbi.nlm.nih.gov/pubmed/35579849
http://dx.doi.org/10.1007/s40292-022-00524-7
_version_ 1784709322464296960
author de Kreutzenberg, Saula Vigili
author_facet de Kreutzenberg, Saula Vigili
author_sort de Kreutzenberg, Saula Vigili
collection PubMed
description Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine is: the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies (ICT) for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, …. Telemedicine has actually represented the most useful and employed tool to maintain contacts between patients and physicians during the period of physical distance imposed by the pandemic, especially during the lockdown. Diabetes in particular, a chronic disease that often needs frequent confronting between patient and health professionals has taken advantage of the telehealth approach. Nowadays, technological tools are more and more widely used for the management of diabetes. In this review results obtained by telemendicine application in type 1 and type 2 diabetic individuals during COVID-19 are revised, and future perspectives for telemedicine use to manage diabetes are discussed.
format Online
Article
Text
id pubmed-9111950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91119502022-05-17 Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience de Kreutzenberg, Saula Vigili High Blood Press Cardiovasc Prev Review Article Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine is: the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies (ICT) for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, …. Telemedicine has actually represented the most useful and employed tool to maintain contacts between patients and physicians during the period of physical distance imposed by the pandemic, especially during the lockdown. Diabetes in particular, a chronic disease that often needs frequent confronting between patient and health professionals has taken advantage of the telehealth approach. Nowadays, technological tools are more and more widely used for the management of diabetes. In this review results obtained by telemendicine application in type 1 and type 2 diabetic individuals during COVID-19 are revised, and future perspectives for telemedicine use to manage diabetes are discussed. Springer International Publishing 2022-05-17 2022 /pmc/articles/PMC9111950/ /pubmed/35579849 http://dx.doi.org/10.1007/s40292-022-00524-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review Article
de Kreutzenberg, Saula Vigili
Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title_full Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title_fullStr Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title_full_unstemmed Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title_short Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
title_sort telemedicine for the clinical management of diabetes; implications and considerations after covid-19 experience
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111950/
https://www.ncbi.nlm.nih.gov/pubmed/35579849
http://dx.doi.org/10.1007/s40292-022-00524-7
work_keys_str_mv AT dekreutzenbergsaulavigili telemedicinefortheclinicalmanagementofdiabetesimplicationsandconsiderationsaftercovid19experience